SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — Ronald Reagan

PatientRonald Reagan
Date of birth1936-02-06
IdentifiersMRN HR-ML008-SYN; SSN (made up) 000-08-6047
Document date2026-07-14
AuthorMargaret Ellison, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month post-fracture, dementia, and caregiver review. [S]

History of Present Illness

Mr. Reagan returns six months after the repair of his right hip fracture. He has had no falls. Home physical therapy finished last month, and he keeps up the home exercise program with supervision. He walks in the house and garden every day with the walker. He had no aches or fever after the zoledronic acid infusion three months ago. The evening restlessness is mild and unchanged. Weekly respite, the home health aide, and caregiver education continue, and the caregiver burden score has fallen. [S]

ElementDetail
Interval changeHome therapy finished; daily walks with the walker; home exercise program
FallsNone since the fracture
Infusion toleranceNo flu-like reaction after zoledronic acid
BehaviorMild evening restlessness, unchanged
FunctionBarthel Index 85; Timed Up and Go 16 seconds
CaregiverZarit Burden Interview 27 of 88, down from 41

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; appetite good; no fever
CardiovascularNegativeNo lightheadedness on standing or fainting
MusculoskeletalNegativeNo hip, thigh, or back pain
NeurologicalPositiveKnown memory loss, unchanged by his caregivers' account
PsychiatricPositiveMild evening restlessness; no low mood; GDS-15 score 3

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Donepezil 10 mg oral tablet, one tablet by mouth daily in the morningOne tablet by mouth daily in the morningOral route2022-03-07activeS
Acetaminophen 500 mg oral tablet, two tablets (1,000 mg) by mouth three times dailyTwo tablets by mouth three times dailyOral route2026-01-14 to 2026-04-14completedS
Oxycodone 5 mg oral tablet, one tablet by mouth every six hours as needed for severe painOne tablet by mouth every six hours as needed for severe painOral route2026-01-14 to 2026-02-10stoppedS
Diphenhydramine 25 mg oral capsule, one capsule by mouth at bedtimeOne capsule by mouth at bedtimeOral route2026-01-16 to 2026-02-10stoppedS
Enoxaparin 40 mg/0.4 mL prefilled syringe, inject 40 mg under the skin daily through day 35 after surgeryInject 40 mg under the skin once dailySubcutaneous route2026-01-14 to 2026-02-17completedS
Cholecalciferol 50 mcg (2,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-02-10activeS
Zoledronic acid 5 mg/100 mL intravenous infusion over at least 15 minutes, once yearly5 mg intravenously over at least 15 minutes once a year; first dose givenIntravenous route2026-04-14 to 2026-04-14completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-14Body height185cmS
2026-07-14Body weight78kgS
2026-07-14Body mass index (BMI) [Ratio]22.8kg/m2S
2026-07-14Systolic blood pressure128mm[Hg]S
2026-07-14Diastolic blood pressure70mm[Hg]S
2026-07-14Heart rate64/minS
2026-07-14Respiratory rate16/minS
2026-07-14Body temperature36.7CelS
2026-07-14Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-14Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-07-14Hemoglobin [Mass/volume] in Blood13.7g/dL13.2-16.6 g/dLNormalS
2026-07-14Total score Barthel Index85{score}S
2026-07-14Geriatric depression scale (GDS) short version total3{score}S

Physical Exam

Vital signs recorded on 2026-07-14; see the Vital Signs section. [S]

SystemFinding
GeneralAlert, cheerful, and sociable
CardiovascularRegular rhythm at 64 per minute; no edema; no fall in blood pressure on standing
MusculoskeletalRight hip incision well healed; painless hip movement; Timed Up and Go 16 seconds with the walker, down from 24 at the first visit
NeurologicalOriented to person, not to date; no focal weakness

Problems

ProblemClinical statusVerificationCodeProvenance
Alzheimer's disease with late onset, disclosed in 1994activeconfirmed G30.1S — Synthetic modern coding of the publicly disclosed diagnosis.
Dementia due to Alzheimer's disease, moderate (FAST stage 5), with evening restlessnessactiveconfirmed F02.B0S — Synthetic stage; his actual stage at this age was not made public.
Osteoporosis with right hip fragility fracture after a fall at home, repaired with internal fixation; subsequent careactiveconfirmed M80.051DS — Synthetic modern coding of the documented January 2001 hip fracture as an osteoporotic fracture; bone density and fracture pattern are synthetic.
Vitamin D deficiencyresolvedconfirmed E55.9S — Synthetic finding from the first-visit 25-hydroxyvitamin D; repleted by three months.
Acute blood loss anemia after hip surgeryresolvedconfirmed D62S — Synthetic postoperative finding; resolved by three months.
History of fallingactiveconfirmed Z91.81S — Synthetic modern coding linked to the documented fall.
Personal history of colon cancer, operated on in 1985activeconfirmed Z85.038S — Synthetic modern coding of the documented 1985 operation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratorySerum calcium after the first zoledronic acid infusionBefore each dose; checked once after the firstCompleted today9.4 mg/dL; no low calcium after the infusion
LaboratoryHemoglobinFollow-up of postoperative anemiaCompleted today13.7 g/dL; anemia resolved
LaboratoryCalcium, phosphorus, and kidney function before the second infusionBefore each intravenous doseDueIn about nine months; phosphorus added after the gap noted at three months
Laboratory25-hydroxyvitamin DYearly after repletionUp to date36 ng/mL three months ago; next in about nine months
ImagingDXAEvery 1 to 3 years on therapyUp to dateBaseline three months ago
ImagingVertebral fracture assessmentAt baseline after a low-trauma fracture or with a T-score of -2.5 or lowerDueMissed at the three-month DXA. Height still 185 cm and no back pain; planned with the next DXA
ExaminationTimed Up and GoWhen home therapy ends, then yearly or with a changeCompleted today16 seconds with the walker, down from 24; above the 12-second threshold
ExaminationCDC STEADI fall-risk screen: fall history, gait and balance, postural blood pressureEvery primary care visit after the fractureCompleted todayNo falls; no fall in blood pressure on standing
ExaminationPain assessmentEvery visitCompleted todayNo pain
ExaminationPhysical and occupational therapy progressEvery visitCompleted todayBarthel Index 85; home therapy finished; home exercise program continues
ExaminationHome safety evaluationAt diagnosis and each follow-upCompleted todayHome safety changes in place; supervision at night
Medication safetyAGS Beers Criteria medication reviewEvery visit and at each transition of careCompleted todayDonepezil and cholecalciferol only; no Beers-listed medicine
Medication safetyCholinesterase inhibitor benefit and tolerabilityEach follow-upCompleted todayHeart rate 64; no fainting; continue
Medication safetyZoledronic acid toleranceAfter each infusionCompleted todayNo acute-phase reaction; no thigh pain
SurveyNeuropsychiatric symptom screen (NPI-Q)Every visitCompleted todayMild evening restlessness, unchanged
SurveyDepression screen (GDS-15)At 1, 3, and 6 months after the fracture; yearly in dementiaCompleted todayScore 3, below the threshold of 5
SurveyCaregiver assessment with the Zarit Burden InterviewAt diagnosis, then every 6 to 12 monthsCompleted today27 of 88, down from 41
SurveyCognitive test (MoCA), FAST stage, and ADL and IADL scoresAt diagnosis, then yearlyUp to dateNext at the yearly dementia review in about seven months
SurveyFRAX 10-year fracture riskAfter the fracture and with each DXADueNot calculated at the three-month DXA; planned with the next DXA
ReferralCaregiver support servicesOngoingCompleted todayWeekly respite, home health aide, and caregiver education continue
Self-managementExercise programOngoingCompleted todayHome exercise program and daily supervised walks
Self-managementAdvance care planningAt diagnosis, yearly, and at stage changesUp to datePOLST completed three months ago; revisit at any change in stage
Self-managementCalcium intake from food and supplementsOngoing; target 1,000 to 1,200 mg a dayCompleted todayCalcium-rich food at each meal

Goal progress:

Guideline basis: Management of Hip Fractures in Older Adults Evidence-Based Clinical Practice Guideline (2021); The clinician's guide to prevention and treatment of osteoporosis (2022); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)

Follow-up: Annual wellness visit in three months. Yearly dementia review in about seven months. Calcium, phosphorus, and kidney function before the second zoledronic acid infusion in about nine months. Next scheduled visit 2026-10-13: subsequent annual wellness visit. [S]